4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001415889-25-015998
Director bought 1,211,198 shares at an average $9.70 ($11,751,304)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-04 | Purchase | +997,864 | $9.63 | $9,609,430 | 9,695,820 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-05 | Purchase | +213,334 | $10.04 | $2,141,873 | 9,909,154 | I |
| Open-market purchases · 1,211,198 sh · avg $9.70 · $11,751,304 | |||||||
Loading xslF345X05/form4-06062025_080635.xml…